arrow_back Back Filing freshness 10-Q Q3 FY2026 SEC EDGAR

download Export Data

Sensei Biotherapeutics, Inc.

FTH

$19.84 ▼ -0.11 (-0.55%) at close

28 Visible periods

22 Metrics

Peer-ranked Benchmarks

Price Chart

Health

Poor

Bearish

auto_awesome

Analytical Summary

Sensei Biotherapeutics, Inc. faces fundamental challenges with weakness in Return on Common Equity (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $512.7M

Dividend Yield —

Revenue Growth —

Op. Margin —

ROIC -10.8% ↘

FCF / Share $-0.50 ↗

Trailing P/E —

Price / Book 3.2x

FCF Yield —

Debt / Equity —

info Valuation on last close. End-of-day price, Nov 5, 2026.

28-Year Financial Trajectory

Quarterly

Metric Value Trend Year over Year Percentile

Net Income Profit after all expenses

$-170.24M

↓ -2380.1% —

FCF / Share Free cash flow per share

$-0.50

↑ +81.9% —

Long-Term Debt Long-term obligations

$567.00K

— 0.0% —

trending_up

Bullish Indicators

No bullish signals detected.

warning

Bearish Risks

Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Returns ↓

Financial Health ↓

Cash Quality ↑

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 3 metrics

Metric	Q3 FY2026 Sep 30, 2026 10-Q ↗	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗
EPS Growth YoY (%)	78.2% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	27.4% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	-2334.3% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	39.4% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	37.6% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	30.2% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	15.6% Good ↑ Good Improving Year-over-year change in earnings per share Optimal: > 10%	-2.8% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	-3.6% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	9.7% Fair ↓ Fair Declining Year-over-year change in earnings per share Optimal: > 10%	3.0% Caution ↓ Caution Declining Year-over-year change in earnings per share Optimal: > 10%	25.0% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	36.4% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	8.8% Fair ↑ Fair Improving Year-over-year change in earnings per share Optimal: > 10%	—	-33.3% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	-37.5% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	—	—	—	—	—	—	—	—	—	—	—
Net Income Growth YoY (%)	-2380.1% Weak ↓ Weak Declining Year-over-year change in net income	-2380.1% Weak ↓ Weak Declining Year-over-year change in net income	-2380.1% Weak ↓ Weak Declining Year-over-year change in net income	39.3% Excellent ↑ Excellent Improving Year-over-year change in net income	14.1% Fair ↑ Fair Improving Year-over-year change in net income	14.1% Fair ↑ Fair Improving Year-over-year change in net income	14.1% Fair ↑ Fair Improving Year-over-year change in net income	-4.8% Weak ↓ Weak Declining Year-over-year change in net income	21.5% Good ↓ Good Declining Year-over-year change in net income	21.5% Good ↓ Good Declining Year-over-year change in net income	21.5% Good ↓ Good Declining Year-over-year change in net income	39.4% Excellent ↑ Excellent Improving Year-over-year change in net income	18.0% Good ↑ Good Improving Year-over-year change in net income	18.0% Good ↑ Good Improving Year-over-year change in net income	18.0% Good ↑ Good Improving Year-over-year change in net income	-30.6% Weak ↑ Weak Improving Year-over-year change in net income	-55.6% Weak ↑ Weak Improving Year-over-year change in net income	-55.6% Weak ↑ Weak Improving Year-over-year change in net income	-55.6% Weak ↑ Weak Improving Year-over-year change in net income	-82.5% Weak ↓ Weak Declining Year-over-year change in net income	-69.9% Weak → Weak Stable Year-over-year change in net income	-69.9% Weak Weak Year-over-year change in net income	-69.9% Weak Weak Year-over-year change in net income	—	—	—	—	—
FCF Growth YoY (%)	—	—	-47.2% Weak Weak Year-over-year change in free cash flow	—	—	—	7.8% Fair Fair Year-over-year change in free cash flow	—	—	—	20.7% Good Good Year-over-year change in free cash flow	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—

💰 Are margins durable? 1 metrics

Metric	Q3 FY2026 Sep 30, 2026 10-Q ↗	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗
FCF / Net Income (x)	0.08x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.09x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.06x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	0.82x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	—	—	1.03x Fair Fair Free cash flow relative to reported net income Optimal: > 1x	0.75x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	—	—	0.96x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	0.83x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	—	—	1.17x Fair ↑ Fair Improving Free cash flow relative to reported net income Optimal: > 1x	0.78x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	—	0.96x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.87x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.90x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	0.75x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	—	1.41x Good ↑ Good Improving Free cash flow relative to reported net income Optimal: > 1x	0.58x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	1.41x Good ↑ Good Improving Free cash flow relative to reported net income Optimal: > 1x	0.59x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	1.39x Good Good Free cash flow relative to reported net income Optimal: > 1x	—

🎯 Is capital allocation efficient? 3 metrics

Metric	Q3 FY2026 Sep 30, 2026 10-Q ↗	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗
Return on Invested Capital (%)	-10.8% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-8.4% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	98.2% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	-21.1% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-16.7% Weak → Weak Stable Return earned on debt + equity capital invested Optimal: > 10%	-15.1% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-18.0% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-17.0% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-13.5% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-11.8% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-11.8% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-9.9% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-8.6% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-10.2% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-9.2% Weak → Weak Stable Return earned on debt + equity capital invested Optimal: > 10%	-10.0% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-9.7% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-6.7% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-7.3% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-5.1% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-5.3% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-4.7% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-3.7% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	7.2% Fair ↓ Fair Declining Return earned on debt + equity capital invested Optimal: > 10%	8.2% Fair → Fair Stable Return earned on debt + equity capital invested Optimal: > 10%	8.2% Fair Fair Return earned on debt + equity capital invested Optimal: > 10%	7.6% Fair Fair Return earned on debt + equity capital invested Optimal: > 10%	—
Return on Capital (%) (%)	-12.3% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-9.7% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-83.1% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-21.6% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-17.6% Weak → Weak Stable Operating profit relative to total assets Optimal: > 10%	-16.4% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-19.0% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-18.2% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-14.7% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-13.0% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-13.1% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-10.9% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-9.5% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-11.4% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-10.2% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-11.0% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-10.8% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	—	-8.3% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-6.1% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	—	-5.8% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-4.6% Weak Weak Operating profit relative to total assets Optimal: > 10%	-23.7% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—	—	—
Return on Common Equity (%) (%)	-105.7% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-804%)	-98.4% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-756%)	124.0% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+727%)	-25.4% Weak → Weak Stable Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-269%)	-29.8% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-299%)	-25.1% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-268%)	-21.5% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-243%)	-20.2% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-235%)	-17.5% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-216%)	-15.3% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-202%)	-13.7% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-191%)	-11.4% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-176%)	-14.3% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-196%)	-12.8% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-186%)	-10.7% Weak → Weak Stable Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-172%)	-11.8% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-179%)	-10.9% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-173%)	-9.9% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-166%)	-9.2% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-161%)	-6.4% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-143%)	-5.1% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-134%)	-4.9% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-133%)	-4.7% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-131%)	9.1% Caution ↓ Caution Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-39%)	9.1% Caution ↓ Caution Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-39%)	10.0% Caution Caution Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-34%)	10.9% Fair Fair Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-27%)	—

⚖️ Is the balance sheet risky? 4 metrics

Metric	Q3 FY2026 Sep 30, 2026 10-Q ↗	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗
Debt to Equity (x)	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	0.00x Excellent ↑ Excellent Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-99%)	0.00x Excellent Excellent Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-99%)	-0.01x Excellent Excellent Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-102%)	—	—	—	—
Interest Coverage (x)	—	—	—	-1652.33x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-808.50x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-520.60x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-559.54x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-486.71x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-372.52x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-324.46x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-311.79x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-262.65x Weak → Weak Stable Operating income divided by interest expense Optimal: > 5x	-234.45x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-267.82x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-262.10x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-63.34x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-1394.10x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-62.28x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-51.39x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-30.76x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-48.21x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-66.56x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-2656.33x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-94.02x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-1788.00x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-1635.67x Weak Weak Operating income divided by interest expense Optimal: > 5x	-2.52x Weak Weak Operating income divided by interest expense Optimal: > 5x	—
Net Debt (USD)	$-14.18M	$-26.90M	$-152.32M	$-8.67M	$-10.56M	$-12.56M	$-9.88M	$-9.99M	$-19.13M	$-11.89M	$-10.96M	$-13.01M	$-11.34M	$-10.23M	$-8.11M	$-17.80M	$-11.45M	—	$-8.72M	$-7.16M	—	$-15.03M	$-168.85M	$-16.03M	—	—	—	—
Debt / EBITDA (x)	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	-0.06x Excellent ↑ Excellent Improving Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.07x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.11x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	—	—	—	—

📊 What does each share earn? 5 metrics

Metric	Q3 FY2026 Sep 30, 2026 10-Q ↗	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗
Basic EPS, GAAP (USD)	$-0.79	$-2.84	$-131.45	$-3.74	$-3.62	$-3.91	$-5.40	$-6.17	$-5.80	$-5.60	$-6.40	$-6.00	$-5.60	$-6.20	$-6.60	$-8.00	$-8.80	$-6.80	—	$-6.00	$-6.40	—	—	—	—	—	—	—
Free Cash Flow per Share (USD)	$-0.50	$-2.78	$-8.29	—	—	—	$-5.63	—	—	—	$-6.11	—	—	—	$-7.70	—	—	$-7.79	—	—	$-3.90	—	—	—	—	—	—	—
Book Value per Share (USD)	$6.23	$6.70	$-102.43	$14.74	$18.24	$21.66	$25.38	$30.49	$36.40	$41.55	$46.64	$51.85	$56.81	$59.59	$61.25	$67.23	$74.21	$82.03	$88.20	$95.73	$101.48	$106.66	$111.97	$-601.92	—	—	—	—
Tangible Book Value per Share (USD)	$6.23	$6.70	$-102.43	$14.74	$18.24	$21.66	$25.38	$30.49	$36.40	$41.55	$46.64	$51.85	$56.81	$59.59	$61.25	$67.23	$74.21	$82.03	$88.20	$95.73	$101.48	$106.66	$111.97	$-601.92	—	—	—	—
Basic Weighted Avg Shares (shares)	25.84M	5.64M	1.30M	—	1.26M	1.26M	1.26M	—	1.26M	1.26M	1.25M	—	1.28M	1.53M	1.54M	—	1.54M	1.54M	—	—	1.53M	—	—	—	—	—	—	—

🏦 How resilient is the balance sheet? 3 metrics

Metric	Q3 FY2026 Sep 30, 2026 10-Q ↗	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗
Working Capital (USD)	$166.81M	$179.08M	$190.04M	$17.26M	$21.35M	$25.70M	$30.45M	$36.48M	$42.66M	$48.99M	$55.24M	$61.61M	$67.61M	$75.71M	$91.03M	$99.52M	$109.99M	—	$131.37M	$143.65M	—	$161.69M	$170.31M	$15.25M	—	—	—	—
LT Debt (USD)	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	$567.00K	$567.00K	$567.00K	—	—	—	—
Total Equity (USD)	$161.10M	$172.96M	$-137.29M	$18.59M	$23.01M	$27.31M	$31.99M	$38.39M	$45.78M	$52.19M	$58.47M	$64.89M	$71.00M	$79.20M	$94.85M	$103.41M	$113.99M	$125.92M	$135.31M	$146.51M	$155.21M	$163.12M	$171.25M	$-56.44M	$-51.68M	$-47.09M	$-42.89M	$-68.66M

📋 What is driving earnings? 3 metrics

Metric	Q3 FY2026 Sep 30, 2026 10-Q ↗	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗
Depreciation Expense (USD)	$17.00K	$25.00K	$29.00K	$30.00K	—	—	$30.00K	$139.00K	$140.00K	$135.00K	$137.00K	$135.00K	$137.00K	$138.00K	$161.00K	$162.00K	$151.00K	$144.00K	$157.00K	$329.00K	$136.00K	$122.00K	$98.00K	$70.00K	$64.00K	$52.00K	$23.00K	—
Net Income, GAAP (USD)	$-170.24M	$-170.24M	$-170.24M	$-4.72M	$-6.86M	$-6.86M	$-6.86M	$-7.77M	$-7.99M	$-7.99M	$-7.99M	$-7.41M	$-10.18M	$-10.18M	$-10.18M	$-12.23M	$-12.40M	$-12.40M	$-12.40M	$-9.37M	$-7.97M	$-7.97M	$-7.97M	$-5.13M	$-4.69M	$-4.69M	$-4.69M	—
Operating Cash Flow (USD)	$-13.00M	$-15.67M	$-10.73M	$-3.86M	—	—	$-7.09M	$-5.79M	—	—	$-7.62M	$-6.16M	—	—	$-11.74M	$-9.57M	—	$-11.90M	$-10.75M	$-7.87M	$-5.58M	—	$-10.77M	$-2.68M	$-5.80M	$-2.77M	$-6.46M	—

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced 4 days ago 7 years · 28 quarters

Sensei Biotherapeutics, Inc.

Analytical Summary

28-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Statement lens

Benchmark Lens

Signals

Percentile Rankings

Peer Comparison

Compare FTH with peers